Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Greater Manchester Mental Health NHS Foundation Trust | OTHER |
Not provided
Not provided
Not provided
The aim of this study is to determine whether it is feasible to deliver a 9-session compassionate-focused therapy for older people with bipolar disorder. Participants will be asked to complete baseline measures and at post-intervention follow-up (12 weeks and 24 weeks) to understand any potential clinical benefits of the therapy.
The present study will evaluate the feasibility of a compassionate-focused intervention targeting rumination that is specifically tailored for older people with bipolar disorder. In addition to evaluating its feasibility, the study will also investigate whether there are any clinical benefits associated with the intervention, namely, any potential reductions in negative rumination and feelings of guilt and shame. To date, there has been no research evaluating the feasibility of this type of intervention.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Therapy participants | Other | Participants to receive the compassionate-focused therapy |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Compassionate-focused therapy | Other | A 9-session therapy intervention targeting negative thinking, feelings of guilt and shame, and cultivating compassion for self and others. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of therapy sessions attended | The primary outcome of the study is the feasibility of the compassionate-focused intervention, which will be measured using the above metric. | The timeframe for number of therapy sessions attended will span the length of intervention; from the first assessment session to final therapy session. The estimated period of time over which the event is assessed is up to 9 weeks. |
| Number of participants who drop-out and at which stage of the intervention | The primary outcome of the study is the feasibility of the compassionate-focused intervention, which will be measured using the above metric. | The time frame covers first therapy session to final therapy session. The estimated period of time over which the event is assessed is up to 9 weeks. |
| Measure | Description | Time Frame |
|---|---|---|
| The Altman Self-Rating Mania Scale | Any preliminary potential clinical benefits will be determined using the following outcome measures. | Changes in outcome measure scores will be recorded from first baseline, to 12 weeks and 24 weeks follow-up |
| The Bipolar Recovery Questionnaire |
| Measure | Description | Time Frame |
|---|---|---|
| The MINI International Neuropsychiatric Interview | Diagnostic interview for Bipolar I or II. | Eligibility portion of the baseline assessments, prior to the intervention. |
| The Hamilton Depression Rating Scale |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Imogen J Young, DClinPsy / MSc / BSc | Contact | 447982314026 | Imogen.Young@postgrad.manchester.ac.uk |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Greater Manchester Mental Health NHS Foundation Trust | Greater Manchester | United Kingdom |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000079562 | Rumination Syndrome |
| D001714 | Bipolar Disorder |
| ID | Term |
|---|---|
| D005767 | Gastrointestinal Diseases |
| D004066 | Digestive System Diseases |
| D001068 | Feeding and Eating Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Any preliminary potential clinical benefits will be determined using the following outcome measures. |
| Changes in outcome measure scores will be recorded from first baseline, to 12 weeks and 24 weeks follow-up |
| The Quality of Life in Bipolar Disorder Questionnaire | Any preliminary potential clinical benefits will be determined using the following outcome measures. | Changes in outcome measure scores will be recorded from first baseline, to 12 weeks and 24 weeks follow-up |
| Other as Shamer Scale | Any preliminary potential clinical benefits will be determined using the following outcome measures. | Changes in outcome measure scores will be recorded from first baseline, to 12 weeks and 24 weeks follow-up |
| Guilt and Shame Questionnaire | Any preliminary potential clinical benefits will be determined using the following outcome measures. | Changes in outcome measure scores will be recorded from first baseline, to 12 weeks and 24 weeks follow-up |
| The Compassionate Engagement and Action Scale | Any preliminary potential clinical benefits will be determined using the following outcome measures. | Changes in outcome measure scores will be recorded from first baseline, to 12 weeks and 24 weeks follow-up |
| Generalised Anxiety Disorder Questionnaire (GAD-7) | Any preliminary potential clinical benefits will be determined using the following outcome measures. | Changes in outcome measure scores will be recorded from first baseline, to 12 weeks and 24 weeks follow-up |
| Center for Epidemiologic Studies Depression Scale (CES-D) | Any preliminary potential clinical benefits will be determined using the following outcome measures. | Changes in outcome measure scores will be recorded from first baseline, to 12 weeks and 24 weeks follow-up |
Assess depression severity.
| Eligibility portion of the baseline assessments, prior to the intervention. |
| Ruminative Response Scale | Assess levels of rumination. | Eligibility portion of the baseline assessments, prior to the intervention. |
| The Montreal Cognitive Assessment (MOCA) | Assessment of cognitive impairment. | Eligibility portion of the baseline assessments, prior to the intervention. |
| D000068105 | Bipolar and Related Disorders |
| D019964 | Mood Disorders |